Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone Metabolism in Adolescents Undergoing GLP-1 Receptor Agonist Therapy
NCT06903923Phase 2Recruiting
- Sponsor
- University of Virginia
- Start
- Jul 2025
- Primary completion
- Feb 2030
- Countries
- 1
01
Overview
Phase 2, open-label trial in obesity (2 arms), sponsored by University of Virginia. Primary endpoint: Volumetric Bone Mineral Density at the distal radius at 24 months. Started Jul 2025; status: recruiting.
02
Conditions
obesity
Beyond the preview
Go deeper on NCT06903923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06903923.